History | Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes | Guidance | NICE

History

Documents created during the development process.

Review proposal consultation

Review proposal consultation

Declaration of interests

Register of interests (PDF 151 KB)

Published:

17 February 2020

Expected publication

Equality Impact Assessment (Guidance development) (PDF 143 KB)

Published:

27 March 2019

Final draft guidance

Final draft guidance
Final appraisal document (PDF 257 KB)

Published:

21 February 2019
Committee papers (PDF 10.97 MB)

Published:

21 February 2019
Public committee slides (PDF 880 KB)

Published:

21 February 2019

Notes

Note

Invitation to participate

Final scope (PDF 247 KB)

Published:

13 June 2018
Final matrix (PDF 266 KB)

Published:

13 June 2018
NICE's response to comments on the draft scope and provisional matrix monotherapy (PDF 249 KB)

Published:

13 June 2018
NICE's response to comments on the draft scope and provisional matrix combination therapy (PDF 286 KB)

Published:

13 June 2018